🔎 Trials Near Me

Home › Mania › California

Mania clinical trials in California

5 studies for Mania are looking for participants at sites in California.

Cities in California

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

  • Neurocrine Clinical Site, Cerritos
  • Neurocrine Clinical Site, Garden Grove
  • Neurocrine Clinical Site, San Diego
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 29, 2026 · NCT07288320

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

  • Proscience Research Group, Culver City
  • Clinical Innovations, Inc. dba CITrials, Riverside
  • Collaborative Neuroscience Research, LLC, Torrance
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

  • Advanced Research Center Inc., Anaheim
  • CITrials, Bellflower
  • Local Institution - 0014, Cerritos
  • and 3 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT06951698

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

  • Advanced Research Center Inc., Anaheim
  • Clinical Innovations, Inc. dba CITrials, Bellflower
  • Local Institution - 0044, Cerritos
  • and 10 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT06929273

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

  • Clinical Innovations, Inc. dba CITrials, Bellflower
  • Inland Psychiatric Medical Group., Chino
  • Proscience Research Group, Culver City
  • and 4 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07140913

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.